HeadlinesBriefing favicon HeadlinesBriefing

Sector Investment 3 Days

×
6 articles summarized · Last updated: v1911
You are viewing an older version. View latest →

Last updated: August 21, 2026, 11:35 PM ET

Healthcare & Specialty Assets

SkyKnight Capital has signed a definitive agreement to acquire Apex Infusion, a specialty infusion provider. Separately, a Warburg-led investor group agreed to buy a controlling interest in PANTHERx Rare in a $7bn deal.

Infrastructure & AI

Korea's NPS saw infra AUM growth slow to 13.4% in 2024, down from 24.2% a year earlier. The company and partners pledged $500bn to treat compute as a new investable asset class – but only if investors recognize "infra" in AI infra. An economics working paper frames the energy-digital loop as a virtuous circle, even as Nvidia inks manager deals that turn theory into $500bn of real buildout.

Renewables Fundraising

CIP reached a $3bn final close for its second growth-market renewables strategy, leaning on strong re-ups from existing LPOCs despite geopolitical headwinds.